Who owns the ADME DRIVE trademark?

The ADME DRIVE trademark is owned by Superluminal Medicines, Inc..

What class is the ADME DRIVE trademark registered in?

The ADME DRIVE trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for ADME DRIVE?

The USPTO serial number for ADME DRIVE is 98212709.

What is the registration number for ADME DRIVE?

ADME DRIVE is registered under USPTO registration number 8188369.

Sealvo

Home Search: ADME DRIVEADME DRIVE #98212709

Back

Updated Oct 6, 2026·23 searches this week

View on USPTO TSDR Find similar marks

ADM

USPTO Trademark Record

REGISTERED

ADME DRIVE

SN 98212709·Reg 8188369·Filed Oct 06, 2023

Owner Superluminal Medicines, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ADME DRIVE (Serial No. 98212709), Registration No. 8188369, is a registered US trademark filed on Oct 06, 2023 by Superluminal Medicines, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: March 24, 2032

Mark Intelligence

ADME DRIVE (Reg. #8188369) is a registered US trademark that has been protecting its owner, Superluminal Medicines, Inc., since 2023. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 06, 2023

SERIAL

98212709

REG#

8188369

REGISTERED

Mar 24, 2026

Filing Information

StatusREGISTERED

Filing DateOct 06, 2023

Serial Number98212709

Registration No.8188369

Registration DateMar 24, 2026

Status DateMar 24, 2026

Published for OppositionJul 09, 2024

Filing Basis & Declarations

Standard Characters ClaimedUse Application Currently

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1788485

480Apr 05, 2024

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Feb 26, 2025

First use in commerce: Aug 14, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

37 events

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Sep 02, 2026

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Sep 02, 2026

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Sep 02, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Mar 24, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 24, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Mar 04, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Mar 04, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 02, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 02, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Feb 24, 2026

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 19, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

SU - NON-FINAL ACTION - WRITTEN

Jan 20, 2026

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Jan 20, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 20, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 20, 2026

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 20, 2026

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 20, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

STATEMENT OF USE PROCESSING COMPLETE

Jan 17, 2026

STATEMENT OF USE PROCESSING COMPLETE

SOU EXTENSION 2 GRANTED

Jan 17, 2026

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 17, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 16, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Aug 29, 2025

TEAS STATEMENT OF USE RECEIVED

SOU TEAS EXTENSION RECEIVED

Aug 29, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Aug 29, 2025

SOU EXTENSION 2 FILED

USE AMENDMENT FILED

Aug 29, 2025

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 04, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Mar 03, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Mar 03, 2025

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Mar 03, 2025

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 03, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jul 09, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 09, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 19, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 04, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

May 28, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 14, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 10, 2023

NEW APPLICATION ENTERED

Other Marks by Superluminal Medicines, Inc.

Additional USPTO filings from the same owner.

SUP

SUPERLUMINAL MEDICINES

98212701

Superluminal Medicines, Inc.

REGISTERED

HYP

HYPERLOOP

98212707

Superluminal Medicines, Inc.

REGISTERED

TAR

TARGET GPS

98212704

Superluminal Medicines, Inc.

PENDING

SUP

SUPERLUMINAL MEDICINES

99365859

Superluminal Medicines, Inc.

PENDING

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

ADM

ADME

79301404

ADME (CY) LTD

REGISTERED

DRI

DRIVE

97224935

KHTS, INC.

REGISTERED

DRI

DRIVE

87490589

DRIVE MARKETING, LLC

REGISTERED

DRI

DRIVE

97978628

SANTANDER CONSUMER USA INC.

REGISTERED

Other Marks by Gregory B. Coy

Additional USPTO filings handled by the same attorney of record.

EAR

EARTH MAMA

87427809

REGISTERED

SUP

SUPERLUMINAL MEDICINES

98212701

REGISTERED

LOG

LogoMark

88429673

REGISTERED

DEC

DECISIONPOINT TECHNOLOGIES

98635370

REGISTERED

ADME DRIVE

Run a conflict check

Other Marks by Superluminal Medicines, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Gregory B. Coy

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company